Stay updated on Phase II Pembrolizumab Plus GVD Clinical Trial

Sign up to get notified when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Pembrolizumab Plus GVD Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a basic header and footer. It shows no study details or locations, indicating the page is currently inaccessible.
    Difference
    23%
    Check dated 2026-09-20T22:34:49.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page's revision marker was bumped from v3.6.5 to v3.6.6, indicating a maintenance/metadata update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-30T22:30:35.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page’s revision history now includes a new entry for v3.6.5 dated 2026-08-07, along with prior August revisions; this indicates an update to the page’s revision history and timestamps.
    Difference
    0.2%
    Check dated 2026-08-09T11:00:38.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, signaling a routine deployment or patch. No study details or user-facing content appears to be altered.
    Difference
    0.0%
    Check dated 2026-07-25T17:52:51.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    ISRT sections were added (PART 3A/3B) with reference to ISRT guidelines for nodal disease. Eligibility criteria were updated to specify PET-based Lugano measurable disease and autoimmune disease exclusions, and the study endpoints include a 5-year disease-free survival assessment.
    Difference
    1%
    Check dated 2026-07-18T15:43:22.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page metadata was updated to reflect a new revision (v3.6.3) and more recent update dates (2026-06-26 and 2026-06-29), indicating an administrative update to the study record.
    Difference
    0.2%
    Check dated 2026-07-04T13:19:10.000Z thumbnail image

Stay in the know with updates to Phase II Pembrolizumab Plus GVD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.